ES2041796T3 - Un procedimiento para preparar una vacuna. - Google Patents
Un procedimiento para preparar una vacuna.Info
- Publication number
- ES2041796T3 ES2041796T3 ES198888305166T ES88305166T ES2041796T3 ES 2041796 T3 ES2041796 T3 ES 2041796T3 ES 198888305166 T ES198888305166 T ES 198888305166T ES 88305166 T ES88305166 T ES 88305166T ES 2041796 T3 ES2041796 T3 ES 2041796T3
- Authority
- ES
- Spain
- Prior art keywords
- vaccine
- preparing
- procedure
- mumps
- saccharose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/20—Rubella virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62142465A JPS63307827A (ja) | 1987-06-08 | 1987-06-08 | 安定化された生ウイルスワクチンおよびその製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2041796T3 true ES2041796T3 (es) | 1993-12-01 |
Family
ID=15315947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198888305166T Expired - Lifetime ES2041796T3 (es) | 1987-06-08 | 1988-06-07 | Un procedimiento para preparar una vacuna. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4985244A (fr) |
EP (1) | EP0295043B1 (fr) |
JP (1) | JPS63307827A (fr) |
KR (1) | KR910009346B1 (fr) |
AT (1) | ATE89742T1 (fr) |
BE (1) | BE1001533A3 (fr) |
DE (1) | DE3881281T2 (fr) |
ES (1) | ES2041796T3 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3045581B2 (ja) * | 1991-10-14 | 2000-05-29 | 社団法人北里研究所 | 麻疹ワクチンウイルス株同定方法 |
CA2075521C (fr) * | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Vaccin vivant stabilise |
AU687497B2 (en) * | 1993-12-21 | 1998-02-26 | Merck & Co., Inc. | Thermostable varicella zoster virus |
US6051238A (en) * | 1996-12-20 | 2000-04-18 | Merck & Co., Inc. | Stabilizers for lyophilized mumps vaccines |
US6290967B1 (en) * | 1996-12-20 | 2001-09-18 | Merck & Co., Inc. | Stabilizers for lyophilized vaccines |
JP2000507963A (ja) * | 1996-12-20 | 2000-06-27 | メルク エンド カンパニー インコーポレーテッド | 凍結乾燥ワクチン用安定剤 |
US6210683B1 (en) | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
GB9808922D0 (en) | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
US6586411B1 (en) * | 2000-08-16 | 2003-07-01 | Mayo Foundation For Medical Education And Research | System for monitoring the location of transgenes |
US6896881B1 (en) * | 1999-09-24 | 2005-05-24 | Mayo Foundation For Medical Education And Research | Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
EP2345721A1 (fr) | 1999-11-12 | 2011-07-20 | Fibrogen, Inc. | Gélatine recombinante dans des vaccins |
GB9930882D0 (en) * | 1999-12-30 | 2000-02-23 | Nps Allelix Corp | GLP-2 formulations |
RU2158134C1 (ru) * | 2000-03-10 | 2000-10-27 | Унитарное Государственное "Московское Предприятие По Производству Бактерийных Препаратов" | Способ получения ассоциированной паротитно-коревой вакцины |
US7118740B1 (en) * | 2000-09-22 | 2006-10-10 | Mayo Foundation For Medical Education And Research | Method for limiting the growth of cancer cells using an attenuated measles virus |
US20060141483A1 (en) * | 2004-12-23 | 2006-06-29 | Calton Gary J | Stabilization of viral compositions |
US9951117B2 (en) | 2010-09-02 | 2018-04-24 | Mayo Foundation For Medical Education And Research | Vesicular stomatitis viruses |
CN103180446A (zh) | 2010-09-02 | 2013-06-26 | 梅约医学教育与研究基金会 | 疱疹性口炎病毒 |
EP2895191B1 (fr) | 2012-09-14 | 2019-06-05 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Protéine brachyury, vecteurs adénoviraux codant pour la protéine brachyury, et leur utilisation |
CN103599530B (zh) * | 2013-10-30 | 2015-04-22 | 天津津斯特疫苗有限责任公司 | 一种用无血清培养基制备风疹减毒活疫苗的方法 |
SG11201610921PA (en) * | 2014-07-18 | 2017-02-27 | Msd Wellcome Trust Hilleman Lab Pvt Ltd | A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof |
MX2017008013A (es) * | 2014-12-18 | 2018-03-06 | Amgen Inc | Formulacion congelada estable de virus de herpes simple. |
CA2994694A1 (fr) | 2015-08-03 | 2017-02-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mutants de deletion de la proteine brachyury, vecteurs sans levure codant pour les mutants de deletion de la proteine brachyury, et leur utilisation |
US20210187100A1 (en) * | 2018-09-06 | 2021-06-24 | Bavarian Nordic A/S | Storage Improved Poxvirus Compositions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2424031A1 (fr) * | 1978-04-24 | 1979-11-23 | Merck & Co Inc | Stabilisateur de vaccin |
PT71926B (en) * | 1979-10-29 | 1982-03-31 | Merck & Co Inc | Process for preparing a liquid vaccine comprising a stabilizer |
US4338335A (en) * | 1980-02-05 | 1982-07-06 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
US4337242A (en) * | 1980-02-05 | 1982-06-29 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
DE3601922A1 (de) * | 1986-01-23 | 1987-07-30 | Behringwerke Ag | Stabilisiertes virus-antigen, verfahren zu seiner herstellung und seine verwendung |
-
1987
- 1987-06-08 JP JP62142465A patent/JPS63307827A/ja active Pending
-
1988
- 1988-04-18 KR KR1019880004414A patent/KR910009346B1/ko not_active IP Right Cessation
- 1988-06-07 DE DE8888305166T patent/DE3881281T2/de not_active Expired - Fee Related
- 1988-06-07 ES ES198888305166T patent/ES2041796T3/es not_active Expired - Lifetime
- 1988-06-07 BE BE8800645A patent/BE1001533A3/fr not_active IP Right Cessation
- 1988-06-07 AT AT88305166T patent/ATE89742T1/de not_active IP Right Cessation
- 1988-06-07 EP EP88305166A patent/EP0295043B1/fr not_active Expired - Lifetime
- 1988-06-08 US US07/203,411 patent/US4985244A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE89742T1 (de) | 1993-06-15 |
EP0295043A2 (fr) | 1988-12-14 |
KR910009346B1 (ko) | 1991-11-12 |
KR890000107A (ko) | 1989-03-11 |
DE3881281D1 (de) | 1993-07-01 |
BE1001533A3 (fr) | 1989-11-21 |
US4985244A (en) | 1991-01-15 |
DE3881281T2 (de) | 1993-09-09 |
EP0295043B1 (fr) | 1993-05-26 |
EP0295043A3 (en) | 1989-07-26 |
JPS63307827A (ja) | 1988-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2041796T3 (es) | Un procedimiento para preparar una vacuna. | |
NZ513202A (en) | Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde | |
DK0745387T3 (da) | Adjuvanser til virale vacciner | |
DK0588578T4 (da) | Præparat, der indeholder både en oplöselig og en uoplöselig form af et immunogen | |
KR890004725A (ko) | 신규 방법 | |
FI873672A (fi) | Kompositioner innehaollande l-3,4-dihydroxifenylalanin. | |
NL300189I1 (nl) | Acellulair vaccin. | |
DK0639640T3 (da) | Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91 | |
FI923347A (fi) | Blodfaktorer producerade med rekombinant-dna-teknik och foerfarande foer expression av naemnda blodfaktorer samt i naemnda foerfarande anvaenda rekombinanta kokoppvirus. | |
ES2113348T3 (es) | Composiciones de vacunas estabilizadas. | |
DK0838222T3 (da) | Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV) | |
HU9202976D0 (en) | Vaccine acting against anaemy of chicken | |
LU91458I2 (fr) | "Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle." | |
NO883520L (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
NZ228232A (en) | Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry | |
IT1223171B (it) | Procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b. bronchiseptica e vaccino ar vivo attenuato cosi' ottenuto | |
ES2055610T3 (es) | Vacuna contra hrsv. | |
NO933628L (no) | Fremgangsmaate og blanding for behandling av Herpes-infeksjoner | |
KR920021163A (ko) | 비-자극성 백신 조성물 | |
SU1483948A1 (ru) | Способ инактивации вируса везикулярной экзантемы свиней | |
FI970318A0 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiitoreina käyttökelpoisia yhdisteitä | |
EP0563288A4 (en) | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines | |
ATE159758T1 (de) | Azelluläre impfstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 295043 Country of ref document: ES |